Patents Assigned to Merck Sante, a corporation of France
  • Publication number: 20030216290
    Abstract: A method of preventing or treating diabetic retinopathy is disclosed including administering to a mammal a therapeutically effective amount of an inhibitor of retinal pericyte apoptosis. Also disclosed is a pharmaceutical composition which treats and/or prevents diabetic retinopathy comprising as an active agent a therapeutically effective amount of at least one inhibitor of retinal pericyte apoptosis and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: April 23, 2003
    Publication date: November 20, 2003
    Applicants: Merck Sante, a corporation of France, INSERM, a corporation of France
    Inventors: Marc Lecomte, Ulriche Denis, Clarisse Paget, Nicolas Wiernsperger, Michel Lagarde